You are here

  • Home
  • Archive
  • Volume 10, Issue 2
  • Eradicating tumor in a recurrent cervical cancer patient with autologous tumor-infiltrating lymphocytes and a modified lymphodepleting regimen

Article info

Article menu
Case report
Eradicating tumor in a recurrent cervical cancer patient with autologous tumor-infiltrating lymphocytes and a modified lymphodepleting regimen

Authors

  • Jing Guo Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Ning Luo Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Guihai Ai Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Weihong Yang Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Jihui Zhu Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Caixia Li Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Rong Chen Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Changbao Zhang Department of Radiology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Shupeng Liu Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of ChinaGynecologic Minimally Invasive Surgery Research Center, School of Medicine, Tongji University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Huajun Jin Gencells Therapeutics, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Zhongping Cheng Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of ChinaGynecologic Minimally Invasive Surgery Research Center, School of Medicine, Tongji University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Zhongping Cheng; mdcheng18{at}263.net; Dr Huajun Jin; hj-jin{at}hotmail.com; Dr Shupeng Liu; lshup{at}tongji.edu.cn
View Full Text

Citation

Guo J, Luo N, Ai G, et al
Eradicating tumor in a recurrent cervical cancer patient with autologous tumor-infiltrating lymphocytes and a modified lymphodepleting regimen
Journal for ImmunoTherapy of Cancer 2022;10:e003887. doi: 10.1136/jitc-2021-003887

Publication history

  • Accepted December 21, 2021
  • First published February 17, 2022.
Online issue publication 
October 18, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.